| Record ID | talis_openlibrary_contribution/talis-openlibrary-contribution.mrc:1220885794:1165 |
| Source | Talis |
| Download Link | /show-records/talis_openlibrary_contribution/talis-openlibrary-contribution.mrc:1220885794:1165?format=raw |
LEADER: 01165cam a22002898a 4500
001 8787ccb3c7a140f0803c0d5168bd0363
003 UK-BiTAL
005 20050705141556.0
008 871120s1988 xxua b 100 ||eng|d
020 $a0932883133 :
035 $a()0932883133
035 $a 87033542
040 $dBN017$dUK-BiTAL
050 00 $aRC692
082 04 $a616.1/36071$219
245 04 $aThe role of cholesterol in atherosclerosis :$bnew therapeutic opportunities : Merck Sharp & Dohme International, Medical Advisory Council, New Milton, Hampshire, England, July 13-14, 1987 /$ceditors, Scott M. Grundy, Alexander G. Bearn.
260 $aPhiladelphia :$bHanley & Belfus,$cc1988.
300 $aix, 261 p. :$bill. ;$c24 cm.
440 0 $aMEDAC, Medical Advisory Council ;$v1987
504 $aIncludes bibliographies and index.
650 0 $aAtherosclerosis$xCongresses.
650 0 $aCholesterol$xPhysiological effects$xCongresses.
650 0 $aAnticholesteremic agents$xCongresses.
650 0 $aBlood lipoproteins$xCongresses.
700 1 $aGrundy, Scott M.
700 1 $aBearn, Alexander G.
710 2 $aMedical Advisory Council (Merck, Sharp & Dohme International)